| 临床特征 | n | miR-423-5p表达量 | t | P | |||||
| 年龄(岁) |
|
| 0.488 | 0.314 | |||||
| <50 | 19 | 3.19 ± 0.31 |
|
| |||||
| ≥50 | 29 | 3.14 ± 0.41 |
|
| |||||
| 性别 |
|
| 0.422 | 0.337 | |||||
| 女 | 18 | 3.19 ± 0.39 |
|
| |||||
| 男 | 30 | 3.15 ± 0.33 |
|
| |||||
| 核分裂数(/50HPF) |
|
| 6.333 | <0.001 | |||||
| ≥5 | 14 | 3.52 ± 0.22 |
|
| |||||
| <5 | 34 | 3.01 ± 0.26 |
|
| |||||
| 肿瘤大小(cm) |
|
| −2.003 | 0.026 | |||||
| <5 | 31 | 3.08 ± 0.32 |
|
| |||||
| ≥5 | 17 | 3.29 ± 0.35 |
|
| |||||
| 危险度分级 |
|
| 2.927 | 0.003 | |||||
| 低危–中危 | 32 | 3.06 ± 0.31 |
|
| |||||
| 高危 | 16 | 3.35 ± 0.33 |
|
| |||||